5 simple steps for targeting a £1,000,000 SIPP

Through regular contributions and careful monitoring, investors can target a seven-figure long-term SIPP to improve their retirement quality of life.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A senior group of friends enjoying rowing on the River Derwent

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Leveraging the power of a Self-Invested Personal Pension (SIPP) is one of the best ways to start building retirement wealth in the stock market. And looking at the latest data from the Office for National Statistics, it’s a step that many Britons may need to consider.

The average pension savings among 60-year-olds is £228,200 for men and £152,600 for women. Yet following the 4% withdrawal rule, that’s barely enough to generate the £14,400 recommended by the Pensions and Lifetime Savings Association to maintain a minimum retirement lifestyle, let alone a moderate or comfortable one.

With that in mind, let’s explore how investors can leverage a SIPP to try and build a £1m pension pot.

How to start

  1. Open a SIPP
  2. Deposit capital regularly
  3. Research investment opportunities
  4. Buy and hold for the long run
  5. Monitor and review

Different SIPP providers charge different fees, and it’s important to compare to find the most suitable platform. It’s also essential to regularly allocate money from a monthly paycheque to a SIPP so there’s capital available to buy quality shares.

Researching investment opportunities is where a lot of hiccups can occur. And for investors who don’t have the time, knowledge, or interest in picking individual stocks, an index fund might be a more suitable approach.

Once the investment decisions have been made, it’s just a matter of executing the trades and holding on for the long run. But of course, investors need to keep their fingers on the pulse to make sure their investment thesis isn’t slowly breaking.

Aiming for a million

Thanks to the tax relief provided by a SIPP, a lot of capital can be built quickly. For example, let’s say an investor’s contributing £500 a month into their pension pot. After tax relief, they could have anywhere between £625 and £1,100, depending on their income tax bracket.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Given enough time, it’s not that difficult to turn £625 a month into £1m. For example, the FTSE 100 has historically provided an average annual return of 8%. And investing £625 a month at this rate would reach £1m within 31 years.

But with stock picking, it’s possible to unlock an even higher return and shorten this journey considerably. Take AstraZeneca (LSE:AZN) as an example.

Today, the healthcare group’s one of the leading forces in cancer therapy, and novel drugs are being used worldwide. But 20 years ago, it was still an up-and-coming pharmaceutical business with a promising pipeline of medicines. Investors who saw the opportunity and capitalised on it have since enjoyed a 13% annualised return.

At this rate, the journey to a million would only take 23 years. And for those happy waiting for the full 30, their SIPPs could reach almost £3m!

Replicating this growth trajectory for new shareholders is likely going to be a challenge with AstraZeneca. After all, even with its impressive current pipeline of drugs, growth is much harder being a £165bn market-cap company. And all it takes is one unfavourable clinical trial result for a new blockbuster drug to send the share price plummeting.

However, it goes to show that by buying and holding quality businesses for the long run, investors can potentially reap tremendous returns.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Is the S&P 500 really that much better than the FTSE 100?

Many believe the S&P 500 will outperform the FTSE 100 in years and decades to come. But is the US…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Is the Shell share price still cheap after strong FY results?

The Shell share price has held up in a year of cheap oil, which brought a progressive dividend rise and…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Alphabet’s $175bn bombshell just sent a message to the entire stock market

Alphabet’s $175bn announcement has sent a big message to the stock market. Get ready investors, artificial intelligence isn't going away…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

A beaten-down tech stock at just 10.8x earnings… an ISA pick for February?

Dr James Fox takes a closer look at one US technology stock that has vastly underperformed the rest of his…

Read more »

A person holding onto a fan of twenty pound notes
Investing Articles

Prediction: in 12 months the battered Diageo share price and dividend could turn £10,000 into…

Royston Wild's taken a hit over the last year as Diageo's share price has crumbled. Can the FTSE 100 company…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Is it time to consider stone-cold Greggs shares?

Greggs shares have experienced a well-publicised decline over the past two years and Dr James Fox isn't surprised. But have…

Read more »

Front view of a young couple walking down terraced Street in Whitley Bay in the north-east of England they are heading into the town centre and deciding which shops to go to they are also holding hands and carrying bags over their shoulders.
Investing Articles

How much does the average Briton need in an ISA for £5,000 of monthly passive income?

Millions of us invest for a passive income. One popular route is buy-to-let investing, but Dr James Fox believes more…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

2 compelling FTSE 250 stocks tipped to grow 100% (or more) in the coming year

Our writer considers two opportunities on the UK’s mid-cap FTSE 250 index that are forecast to double within 12 months.…

Read more »